HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bastian von Tresckow Selected Research

Hodgkin Disease (Hodgkin's Disease)

10/2022Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.
1/2022Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group.
1/2022Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i).
12/2021Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis.
10/2021In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection.
10/2021Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
4/2021Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
1/2021Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial.
1/2021Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.
1/2021PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bastian von Tresckow Research Topics

Disease

51Hodgkin Disease (Hodgkin's Disease)
10/2022 - 04/2004
13Neoplasms (Cancer)
10/2021 - 05/2007
3Infections
10/2022 - 01/2017
3Lymphoma (Lymphomas)
11/2019 - 01/2007
2COVID-19
10/2022 - 12/2021
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2022
2Residual Neoplasm
10/2021 - 03/2013
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 04/2004
2Second Primary Neoplasms (Neoplasms, Second)
01/2020 - 01/2017
2Fever (Fevers)
01/2019 - 04/2015
1Hematologic Diseases (Blood Diseases)
10/2022
1Dyspnea (Shortness of Breath)
10/2022
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2021
1Lymphadenopathy
12/2021
1Thymus Hyperplasia
12/2021
1Deglutition Disorders (Dysphagia)
01/2021
1Mucositis
01/2021
1Vitamin D Deficiency
12/2019
1Pulmonary Embolism
02/2019
1Hematologic Neoplasms (Hematological Malignancy)
02/2019
1Hypercalcemia (Milk Alkali Syndrome)
02/2019
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019
1Thromboembolism
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2018
1Renal Cell Carcinoma (Grawitz Tumor)
12/2018
1Exanthema (Rash)
12/2018
1Fatigue
12/2018
1Melanoma (Melanoma, Malignant)
12/2018
1Pneumonia (Pneumonitis)
12/2018
1Heart Diseases (Heart Disease)
01/2017
1Long Term Adverse Effects
01/2017
1Headache (Headaches)
04/2015
1Nausea
04/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2014
1Multiple Myeloma
03/2014
1Pathologic Complete Response
12/2011

Drug/Important Bio-Agent (IBA)

10Brentuximab VedotinIBA
01/2022 - 10/2013
8Doxorubicin (Adriamycin)FDA LinkGeneric
04/2021 - 08/2009
7Bleomycin (Blenoxane)FDA LinkGeneric
04/2021 - 03/2012
7Vinblastine (Vinblastine Sulfate)FDA Link
04/2021 - 12/2011
6Dacarbazine (DIC)FDA LinkGeneric
04/2021 - 03/2012
4pembrolizumabIBA
01/2020 - 07/2017
3Chimeric Antigen ReceptorsIBA
06/2022 - 01/2022
3Prednisone (Sone)FDA LinkGeneric
04/2021 - 12/2011
3Vincristine (Oncovin)FDA LinkGeneric
04/2021 - 08/2015
3NivolumabIBA
01/2021 - 12/2018
3Rituximab (Mabthera)FDA Link
01/2020 - 10/2011
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2021 - 01/2017
2Etoposide (VP 16)FDA LinkGeneric
04/2021 - 01/2017
2Procarbazine (Matulane)FDA Link
04/2021 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2020
2Pharmaceutical PreparationsIBA
12/2018 - 04/2015
2LigandsIBA
12/2018 - 08/2009
2GemcitabineFDA Link
12/2011 - 08/2009
1Nucleic AcidsIBA
10/2022
1Oxygen (Dioxygen)IBA
10/2022
1ibrutinibIBA
10/2022
1tisagenlecleucelIBA
01/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2022
1EverolimusFDA Link
01/2022
1Messenger RNA (mRNA)IBA
12/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2021
1Cell-Free Nucleic AcidsIBA
10/2021
1Programmed Cell Death 1 ReceptorIBA
12/2020
1AntibodiesIBA
12/2020
1Vitamin DFDA LinkGeneric
12/2019
1Cholecalciferol (Vitamin D3)FDA Link
12/2019
1Histone Deacetylase InhibitorsIBA
02/2019
1domatinostatIBA
02/2019
1EnzymesIBA
02/2019
1venetoclaxIBA
01/2019
1Lenalidomide (CC 5013)FDA Link
01/2019
1obinutuzumabIBA
01/2019
1Monoclonal AntibodiesIBA
12/2018
1PanobinostatIBA
01/2017
1Immune Checkpoint InhibitorsIBA
01/2016
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2015
1JNJ-40346527IBA
04/2015
1ErbB Receptors (EGF Receptor)IBA
03/2014
1Cetuximab (Erbitux)FDA Link
03/2014
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2009
1NF-kappa B (NF-kB)IBA
08/2009
1Annexin A5IBA
08/2009
1Molecular Chaperones (Chaperone, Molecular)IBA
08/2009
1Natural Killer Cell ReceptorsIBA
08/2009
16- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamineIBA
08/2009
1Natural Cytotoxicity Triggering Receptor 3IBA
12/2007
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2007

Therapy/Procedure

20Drug Therapy (Chemotherapy)
01/2022 - 12/2011
13Therapeutics
10/2022 - 09/2011
9Radiotherapy
01/2021 - 12/2011
5Stem Cell Transplantation
01/2020 - 06/2013
4Aftercare (After-Treatment)
10/2021 - 12/2018
2Transplantation
11/2019 - 07/2017
2Immunotherapy
05/2007 - 01/2007
1Hematopoietic Stem Cell Transplantation
01/2019
1Drug Tapering
08/2015
1Autologous Transplantation
09/2011